ADAMTS13 and neoplasm: Factors such as impaired liver function, chronic liver inflammation, fibrosis, cirrhosis, increased systemic inflammation, tumor-associated cytokines (e.g., IL-6, TNF-α), tumor hypoxia, and elevated VWF levels in HCC may also contribute to a relative deficiency of ADAMTS13.